GLP-1 Agonist Manufacturing

• Innovations and Advancements

  There are many new improvements and concepts developed over the years in this area of research, for example OT that has been continued to make GLP-1 medications more effective. One major advantage is that many of these GLP-1 agents have much longer half-lives. It also lessens how often people would need to consume them, making for a more discrete diabetes management.

• Quality Control and Safety Measures in GLP-1 Agonist Manufacturing

  Obviously, the GLP-1 drugs must be safe and they have to work for those who require them. The system of careful monitoring, testing and examination is also in place to see whether the unit itself wherever these medicines are being produced adheres with national quality standards. This is to make sure that every batch of a medicine meets the necessary safety level.

• A Key Contributor to Diabetes Managemen

  The raw herbs with which the medicine is made are also tested to ensure that they were what was expected, and of sufficient/pure enough quality. You will come to know this by the check/bench testing that is performed during numerous stages of manufacturing ensuring that you manufacture a consistent confection and which can be safely consumed. This is consistent with how most best practices are supposed to work in order to maintain the standard of quality that lets us be a tad bit sure that things will function correctly and safely.

Why choose Yaohai GLP-1 Agonist Manufacturing?

• Professional Expertise & Extensive Experience

  Yaohai Bio-Pharma is a leading Microbial biologics CDMO. We have been focused on microbial-produced therapeutics and vaccines for human, veterinary, and the management of pet health. We are equipped with GLP-1 Agonist Manufacturing RD platforms as well as manufacturing technology that encompass the entire process beginning with the development of microbial strains cells, methods and processes, to commercial and clinical manufacturing which ensures successful implementation of cutting-edge solutions. We have acquired a large amount of experience in bio processing of microbial cells. We have delivered over 200 global projects, and help our clients with navigating the laws from the US FDA, EU EMA, Australia TGA, and China NMPA. Our professional expertise and extensive experience allows us to quickly respond to market demands and provide tailored CDMO services.

• Customization, Efficiency & Cost-Effectiveness

  Yaohai Bio-Pharma is GLP-1 Agonist Manufacturing in microbial-derived biologics. We offer custom RD as well as manufacturing solutions, while minimising the risk. We've been involved in numerous modalities like recombinant subunit vaccines, peptides hormones, cytokines growth factors, single-domain antibodies, enzymes, plasmid DNA, the mRNA, and other. We are experts in several Microbial hosts, such as yeast extracellular and intracellular (yield up to 15 grams per liter) bacteria periplasmic secretion as well as soluble intracellular inclusion bodies (yield up to 10 grams/L). Additionally, we have developed the BSL-2 microbial fermentation platform for the development of bacterial vaccines. We have a track record of improving production processes, thereby increasing yields, and reducing costs. With a highly efficient technology team, we guarantee prompt and reliable project delivery and bring your products to market quicker.

• Quality System & Global Regulatory Compliance

  Yaohai BioPharma, a top 10 GLP-1 Agonist Manufacturing, combines regulatory affairs and quality control. We have a quality system that is compliant with current GMP standards and regulations around the globe. Our regulatory team has deep understanding of world-wide regulatory frameworks. This lets us accelerate biological launches. We ensure traceable production procedures with high-quality products as well as compliance with the regulations of the US FDA and EU EMA. Australia TGA and China NMPA is also fulfilled. Yaohai BioPharma successfully passed an in-person audit conducted by an accredited Qualified Person of the European Union (QP) to examine our GMP system and production facility. We have also passed the initial certification audits of the ISO9001 Quality Management System and ISO14001 Environmental Management System.

• Robust Supply Chain & Manufacturing Capabilities

  Yaohai Bio-Pharma, a top 10 GLP-1 Agonist Manufacturing of biological products, is a specialist in microbial fermentation. We have set up a modern facility that has robust RD capabilities and advanced infrastructure. Five lines of production for drugs conforming to GMP standards to purify and ferment microbial cells along with two fill and finish lines for vials as well as cartridges and needles pre-filled are readily available. The fermentation scales available for use range from 100L to 2000L. Filling specifications for vias are 1ml to 25ml, whereas pre-filled syringe or cartridge filling requirements are between 1-3ml. The production workshop is cGMP certified and offers the availability of commercial and clinical samples. The large molecules manufactured in our facility are available for delivery worldwide.

Related product categories

Not finding what you're looking for?
Contact our consultants for more available products.